Cargando…

Pharmacogenomics Testing Confirmation of Carbamazepine Induced DRESS Reaction of an HLA-A*31:01 Positive, Polypharmacy Patient

Pharmacogenomics (PGx) melds well with polypharmacy as another tool to identify medication related problems (MRPs) more specifically so they may be solved most effectively. PGx can pre-emptively assist in medication selection, medication dosing or identify better medications for patients already tak...

Descripción completa

Detalles Bibliográficos
Autores principales:	Speicher, Leigh, Crosby, Sheena, Schuh, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	University of Minnesota Libraries Publishing 2021
Materias:	Case Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401381/ https://www.ncbi.nlm.nih.gov/pubmed/36033112 http://dx.doi.org/10.24926/iip.v12i4.4341

Ejemplares similares

Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report
por: Schuh, Michael J., et al.
Publicado: (2021)

The HLA-A*31:01 allele: influence on carbamazepine treatment
por: Yip, Vincent Lai Ming, et al.
Publicado: (2017)

HLA-A*31:01 and HLA-B*15:02 as genetic markers for carbamazepine hypersensitivity in children
por: Amstutz, Ursula, et al.
Publicado: (2013)

Abs No: HLA-A*31:01 positive hypersensitive patient
por: Lichtenfels, Maike, et al.
Publicado: (2014)

The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam
por: Nguyen, Ai-Hoc, et al.
Publicado: (2023)

Pharmacogenomics (PGx) Patient with Mixed Levels of Actionable Variant Evidence
por: Schuh, Michael J., et al.
Publicado: (2020)

Amoxicillin-Induced Hypersensitivity After DRESS To Carbamazepine
por: Aouam, Karim, et al.
Publicado: (2010)

HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese
por: Nguyen, Dinh Van, et al.
Publicado: (2015)

The Mechanistic Differences in HLA-Associated Carbamazepine Hypersensitivity
por: Simper, Gwendolin S., et al.
Publicado: (2019)

Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) induced by carbamazepine: a case report and literature review
por: EL Omairi, Nissrine, et al.
Publicado: (2014)

Identification of the novel HLA‐B*51:01:01:78 allele and confirmation of extended sequence of B*18:01:26
por: Ulrich, Silvia, et al.
Publicado: (2022)

Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02
por: Simper, Gwendolin S., et al.
Publicado: (2018)

Pharmacogenomic Approaches for Automated Medication Risk Assessment in People with Polypharmacy
por: Liu, Jiazhen, et al.
Publicado: (2018)

Drug Hypersensitivity to Previously Tolerated Phenytoin by Carbamazepine-induced DRESS Syndrome
por: Kim, Cheol-Woo, et al.
Publicado: (2006)

Carbamazepine-induced DRESS syndrome leading to reversible myocarditis in a child
por: Çetin, Mecnun, et al.
Publicado: (2019)

Dress syndrome following carbamazepine exposure: A very early onset
por: Kraiem, M., et al.
Publicado: (2021)

HLA-B*57:01/Carbamazepine-10,11-Epoxide Association Triggers Upregulation of the NFκB and JAK/STAT Pathways
por: Haukamp, Funmilola Josephine, et al.
Publicado: (2023)

Precision Medicine: Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy
por: Michaud, Veronique, et al.
Publicado: (2021)

Single Nucleotide Variants as Proxies for HLA-A*31:01 in Native American Populations
por: Fernandes, Vanessa Câmara, et al.
Publicado: (2022)

Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis
por: Biswas, Mohitosh, et al.
Publicado: (2022)

HLA-E*01:01 + HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03 + HLA-E*01:03 genotype is associated with more severe disease
por: Hosseini, Ehteramolsadat, et al.
Publicado: (2023)

Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients
por: Sukasem, Chonlaphat, et al.
Publicado: (2018)

The Pharmacogenomic HLA Biomarker Associated to Adverse Abacavir Reactions: Comparative Analysis of Different Genotyping Methods
por: Stocchi, Laura, et al.
Publicado: (2012)

HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure
por: Khor, Seik-Soon, et al.
Publicado: (2021)

Characterization of Drug-Specific CD4(+) T-Cells Reveals Possible Roles of HLA Class II in the Pathogenesis of Carbamazepine Hypersensitivity Reactions
por: Jaruthamsophon, Kanoot, et al.
Publicado: (2023)

Towards Evidence-Based Implementation of Pharmacogenomics in Southern Africa: Comorbidities and Polypharmacy Profiles across Diseases
por: Soko, Nyarai Desiree, et al.
Publicado: (2023)

Pension Fund Actuarial Review at 31.12.1997 / 01.01.1998 Position and Recommendation of the Governing Board
Publicado: (1998)

Human Leukocyte Antigen (HLA)-DRB1*15:01 and HLA-DRB5*01:01 Present Complementary Peptide Repertoires
por: Scholz, Erika Margaret, et al.
Publicado: (2017)

Pharmacogenomics of adverse drug reactions
por: Daly, Ann K
Publicado: (2013)

A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
por: Kloypan, Chiraphat, et al.
Publicado: (2021)

DRESS Syndrome Secondary to Carbamazepine Therapy Presenting with Bilateral Acute Anterior Uveitis and Angle Closure Glaucoma
por: Karuppannasamy, Divya, et al.
Publicado: (2019)

Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand
por: Tiwattanon, Kanyawan, et al.
Publicado: (2022)

Actuarial Reviews as at 31.12.2000 / 01.01.2001 - Summary of the two Reviews, Position and Proposals of the Governing Board
Publicado: (2002)

HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02
por: Martín, Paloma, et al.
Publicado: (2015)

Validation of Single Nucleotide Variant Assays for Human Leukocyte Antigen Haplotypes HLA-B*15:02 and HLA-A*31:01 Across Diverse Ancestral Backgrounds
por: Buchner, Amanda, et al.
Publicado: (2021)

Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to Typing HLA-B*57:01 in HIV-1-Positive Patients
por: Falasca, Francesca, et al.
Publicado: (2016)

Comparison of a New In-House and Three Published HLA-B*15:02 Screening Methods for Prevention of Carbamazepine-Induced Severe Drug Reactions
por: Jaruthamsophon, Kanoot, et al.
Publicado: (2016)

Usage Pattern of Carbamazepine and Associated Severe Cutaneous Adverse Reactions in Singapore Following Implementation of HLA-B*15:02 Genotyping as Standard-of-Care
por: Sung, Cynthia, et al.
Publicado: (2020)

Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomics
por: Ade, Catherine M, et al.
Publicado: (2023)

Pharmacogenomics and adverse drug reactions in children
por: Rieder, Michael J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ghm7iavnlcmop86tm92bcui167